 |
PDBsum entry 4hep
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
4hep
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Viral protein
|
 |
|
Title:
|
 |
Complex of lactococcal phage tp901-1 with a llama vhh (vhh17) binder (nanobody)
|
|
Structure:
|
 |
Bpp. Chain: a. Synonym: baseplate protein. Engineered: yes. Vhh17 domain. Chain: g. Engineered: yes
|
|
Source:
|
 |
Lactococcus phage tp901-1. Organism_taxid: 35345. Gene: bpp, orf49. Expressed in: escherichia coli. Expression_system_taxid: 562. Lama glama. Llama. Organism_taxid: 9844.
|
|
Resolution:
|
 |
|
1.75Å
|
R-factor:
|
0.198
|
R-free:
|
0.204
|
|
|
Authors:
|
 |
A.Desmyter,S.Spinelli,C.Farenc,S.Blangy,C.Bebeacua,D.Van Sinderen, J.Mahony,C.Cambillau
|
|
Key ref:
|
 |
A.Desmyter
et al.
(2013).
Viral infection modulation and neutralization by camelid nanobodies.
Proc Natl Acad Sci U S A,
110,
E1371.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
04-Oct-12
|
Release date:
|
20-Mar-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
110:E1371
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Viral infection modulation and neutralization by camelid nanobodies.
|
|
A.Desmyter,
C.Farenc,
J.Mahony,
S.Spinelli,
C.Bebeacua,
S.Blangy,
D.Veesler,
D.van Sinderen,
C.Cambillau.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Lactococcal phages belong to a large family of Siphoviridae and infect
Lactococcus lactis, a gram-positive bacterium used in commercial dairy
fermentations. These phages are believed to recognize and bind specifically to
pellicle polysaccharides covering the entire bacterium. The phage TP901-1
baseplate, located at the tip of the tail, harbors 18 trimeric receptor binding
proteins (RBPs) promoting adhesion to a specific lactococcal strain. Phage
TP901-1 adhesion does not require major conformational changes or Ca(2+), which
contrasts other lactococcal phages. Here, we produced and characterized llama
nanobodies raised against the purified baseplate and the Tal protein of phage
TP901-1 as tools to dissect the molecular determinants of phage TP901-1
infection. Using a set of complementary techniques, surface plasmon resonance,
EM, and X-ray crystallography in a hybrid approach, we identified binders to the
three components of the baseplate, analyzed their affinity for their targets,
and determined their epitopes as well as their functional impact on TP901-1
phage infectivity. We determined the X-ray structures of three nanobodies in
complex with the RBP. Two of them bind to the saccharide binding site of the RBP
and are able to fully neutralize TP901-1 phage infectivity, even after 15
passages. These results provide clear evidence for a practical use of nanobodies
in circumventing lactococcal phages viral infection in dairy fermentation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |
|